Literature DB >> 19573804

Breast cancer SRC activity: bad to the bone.

Dennis C Sgroi1.   

Abstract

Bone metastases are a major cause of breast cancer morbidity and mortality. In this issue of Cancer Cell, Zhang and colleagues identify a Src activation expression signature associated with late-onset breast cancer bone metastases and provide evidence for Src as a key mediator of survival signals in latent bone metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573804     DOI: 10.1016/j.ccr.2009.06.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  4 in total

1.  PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.

Authors:  Hamid H Gari; Gregory D DeGala; Rahul Ray; M Scott Lucia; James R Lambert
Journal:  Cancer Lett       Date:  2016-07-21       Impact factor: 8.679

2.  Regulation of SRC family kinases in human cancers.

Authors:  Banibrata Sen; Faye M Johnson
Journal:  J Signal Transduct       Date:  2011-04-04

3.  Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells.

Authors:  Guoquan Wang; Xiao Wang; Xiaoping Huang; Huiyong Yang; Suqiu Pang; Xiaolan Xie; Shulan Zeng; Junsheng Lin; Yong Diao
Journal:  Cancer Cell Int       Date:  2016-12-01       Impact factor: 5.722

4.  Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.

Authors:  Keyue Shen; Samantha Luk; Daniel F Hicks; Jessica S Elman; Stefan Bohr; Yoshiko Iwamoto; Ryan Murray; Kristen Pena; Fangjing Wang; Erkin Seker; Ralph Weissleder; Martin L Yarmush; Mehmet Toner; Dennis Sgroi; Biju Parekkadan
Journal:  Nat Commun       Date:  2014-12-09       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.